Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (002932.SZ)
CNY 18.76
(-0.74%)
CNY 18.76
(-0.74%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -966.52 Million CNY | 58.91% |
| 2022 | -2.35 Billion CNY | -105.28% |
| 2021 | -1.14 Billion CNY | -117.16% |
| 2020 | -527.61 Million CNY | -209.42% |
| 2019 | -170.51 Million CNY | 34.96% |
| 2018 | -262.17 Million CNY | -110.3% |
| 2017 | -124.66 Million CNY | -40.72% |
| 2016 | -88.58 Million CNY | 8.94% |
| 2015 | -97.28 Million CNY | -822.71% |
| 2014 | -10.54 Million CNY | -93.3% |
| 2013 | -5.45 Million CNY | -448.23% |
| 2012 | -994.92 Thousand CNY | -58.25% |
| 2011 | -628.69 Thousand CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -462.58 Million CNY | 36.6% |
| 2024 Q1 | -956.9 Million CNY | 1.0% |
| 2024 Q2 | -729.58 Million CNY | 23.76% |
| 2023 Q2 | -1.95 Billion CNY | 34.35% |
| 2023 FY | -966.52 Million CNY | 58.91% |
| 2023 Q1 | -2.97 Billion CNY | -26.59% |
| 2023 Q4 | -966.52 Million CNY | 56.01% |
| 2023 Q3 | -2.19 Billion CNY | -12.43% |
| 2022 FY | -2.35 Billion CNY | -105.28% |
| 2022 Q4 | -2.35 Billion CNY | -84.67% |
| 2022 Q3 | -1.27 Billion CNY | 2.5% |
| 2022 Q2 | -1.3 Billion CNY | 6.5% |
| 2022 Q1 | -1.39 Billion CNY | -21.95% |
| 2021 FY | -1.14 Billion CNY | -117.16% |
| 2021 Q4 | -1.14 Billion CNY | -79.83% |
| 2021 Q3 | -637.12 Million CNY | 21.45% |
| 2021 Q1 | -610.76 Million CNY | -15.76% |
| 2021 Q2 | -811.14 Million CNY | -32.81% |
| 2020 Q3 | -334.39 Million CNY | -14.54% |
| 2020 FY | -527.61 Million CNY | -209.42% |
| 2020 Q1 | -179.73 Million CNY | -5.41% |
| 2020 Q2 | -291.94 Million CNY | -62.43% |
| 2020 Q4 | -527.61 Million CNY | -57.78% |
| 2019 Q1 | -332.3 Million CNY | -26.75% |
| 2019 Q2 | -324.39 Million CNY | 2.38% |
| 2019 Q4 | -170.51 Million CNY | 40.94% |
| 2019 Q3 | -288.72 Million CNY | 11.0% |
| 2019 FY | -170.51 Million CNY | 34.96% |
| 2018 Q3 | -205.25 Million CNY | -112.02% |
| 2018 Q1 | -76.21 Million CNY | 38.86% |
| 2018 Q2 | -96.8 Million CNY | -27.02% |
| 2018 FY | -262.17 Million CNY | -110.3% |
| 2018 Q4 | -262.17 Million CNY | -27.73% |
| 2017 Q4 | -124.66 Million CNY | 0.0% |
| 2017 Q1 | 120.3 Million CNY | 226.23% |
| 2017 Q2 | -64.61 Million CNY | -153.7% |
| 2017 FY | -124.66 Million CNY | -40.72% |
| 2016 Q4 | -95.3 Million CNY | 0.0% |
| 2016 FY | -88.58 Million CNY | 8.94% |
| 2016 Q3 | -95.3 Million CNY | -34.16% |
| 2016 Q2 | -71.03 Million CNY | 0.0% |
| 2016 Q1 | -71.03 Million CNY | 30.44% |
| 2015 Q3 | -102.12 Million CNY | -104.15% |
| 2015 Q2 | -50.02 Million CNY | 0.0% |
| 2015 Q4 | -102.12 Million CNY | 0.0% |
| 2015 FY | -97.28 Million CNY | -822.71% |
| 2015 Q1 | -50.02 Million CNY | -374.48% |
| 2014 Q2 | -28.12 Million CNY | 0.0% |
| 2014 FY | -10.54 Million CNY | -93.3% |
| 2014 Q3 | -10.54 Million CNY | 62.51% |
| 2014 Q1 | -28.12 Million CNY | -415.56% |
| 2014 Q4 | -10.54 Million CNY | 0.0% |
| 2013 Q1 | 994.92 Thousand CNY | 0.0% |
| 2013 Q3 | -5.45 Million CNY | 0.0% |
| 2013 Q4 | -5.45 Million CNY | 0.0% |
| 2013 FY | -5.45 Million CNY | -448.23% |
| 2012 FY | -994.92 Thousand CNY | -58.25% |
| 2011 FY | -628.69 Thousand CNY | 0.0% |